thiobutabarbital and Metabolic-Diseases

thiobutabarbital has been researched along with Metabolic-Diseases* in 1 studies

Other Studies

1 other study(ies) available for thiobutabarbital and Metabolic-Diseases

ArticleYear
Hemodynamic effects of potent and selective JNK inhibitors in anesthetized rats: implication for targeting protein kinases in metabolic diseases.
    Bioorganic & medicinal chemistry letters, 2007, Jan-15, Volume: 17, Issue:2

    The hemodynamic effects of a series of potent and selective 4-aminopyridine carboxamide-based pan-JNK inhibitors were assessed in an anesthetized rat model. The effects of these agents on mean arterial pressure, heart rate, cardiac contractility, and peripheral vascular resistance are described, and the implication for targeting protein kinases in metabolic diseases is discussed.

    Topics: Aminopyridines; Anesthesia; Anesthetics; Animals; Blood Pressure; Enzyme Inhibitors; Heart Rate; Male; MAP Kinase Kinase 4; Metabolic Diseases; Myocardial Contraction; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiopental; Vascular Resistance; Ventricular Function, Left

2007